Phase II study of ixabepilone in patients with metastatic breast cancer and a prospective evaluation of its effects on the ultrastructure of neurons
Study Status
Open to Enrollment
Study Description
This study will look at neurological changes in patients with metastatic breast cancer who receive ixabepilone chemotherapy.
Disease Status and/or Stage
Metastatic Breast Cancer
Sponsor
Weill Cornell Medical College; Bristol-Myers Squibb
Key Eligibility
- Age 18 and over
- Stage IV breast cancer
- Life expectancy greater than 3 months
- Additional eligibility criteria will be discussed with you when you contact the study team
Principal Investigator
Contact
- Marta Cobham, RN
- 212-821-0780
- [email protected]
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Erica Bersin
Tel: (646) 962-8232
[email protected]